Correction of abnormal T-cell receptor repertoire during interferon-α therapy in patients with hairy cell leukemia

Blood

Volumn 91, Issue 11, 1998, Pages 4224-4231

  Kluin Nelemans, Hanneke C ^a   Kester, Michel G D ^b   Van De Corput, Lisette ^b   Boor, Patrick P C ^b   Landegent, Jim E ^b   Van Dongen, Jacques J M ^b   Willemze, Roel ^b   Falkenburg, J H Frederik ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN;

ARTICLE; B CELL LEUKEMIA; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; DNA DETERMINATION; HAIRY CELL LEUKEMIA; HEMATOPOIESIS; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION;

EID: 0032100488     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4224.411k19_4224_4231     Document Type: Article

References (38)

1. Kluin-Nelemans JC, Kester MGD, Melenhorst JJ, Landegent JE, Corput van de L, Willemze R, Falkenburg JHF: Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 87:3795, 1996
2. Golomb HM, Hadad LJ: Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 16:393, 1984
3. Westbrook CA, Golde DW: Clinical problems in hairy cell leukemia: Diagnosis and management. Semin Oncol 11:514, 1984
4. Hersh EM, Quesada J, Keating MJ, Rasmussen S, Murphy SG, Gschwind C, Morgan J: Host defence factors and prognosis in hairy cell leukemia. Leuk Res 6:625, 1982
5. Sabbe LJ, Meijer CJLM, Jansen J: T lymphocyte function in hairy cell leukemia. Clin Exp Immunol 42:336, 1980
6. Knight RA, Worman CP, Cawley JC: Detective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukemia. Clin Exp Immunol 53:600, 1983
7. Kluin-Nelemans JC: Hairy cell leukemia and its T cell interactions. Leuk Lymphoma 4:159, 1991
8. Bouroncle BA: Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 14:1, 1994 (suppl 1)
9. Chang KL, Stroup R, Weiss LM: Hairy cell leukemia: Current status. Am J Clin Pathol 97:719, 1992
10. Golomb HM, Ellis E: Treatment options for hairy-cell leukemia. Semin Oncol 18:7, 1991 (suppl 7)
11. Foa R, Fierro MT, Lusso P, Bonferroni M, Raspadori D, Buzzi M, Zinzani PL, Resegotti L, Lauria F: Effect of α-interferon on the immune system of patients with hairy cell leukemia. Leukemia 1:377, 1987
12. Aderka D, Levo Y, Ramot B, Michalevicz R, Meytes D, Shaklai M, Hahn T, Holtmann H, Revel M, Wallach D: Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy. Cancer 60: 2208, 1987
13. Lauria F, Foa R, Raspadori D, Zinzani PL, Buzzi M, Fierro MT, Bonferroni M, Fanin R, Gallizia C, Michieli MG, Degani G, Resegotti L, Tura S: Treatment of hairy-cell leukemia with α-Interferon (α-IFN). Eur J Cancer Clin Oncol 24:195, 1988
14. Jaiyesimi IA, Kantarjian HM, Estey EH: Advances in therapy for hairy cell leukemia: A review. Cancer 72:5, 1993
15. Saven A, Piro L: Drug therapy: Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 330:691, 1994
16. Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchison RE, Corbett WEN, Cassileth PA, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson BD: Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An intergroup study. J Clin Oncol 13:974, 1995
17. Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, Stass S, Freireich EJ: Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79:882, 1992
18. Ho AD, Männel DN, Wulf G, Kirchner H, Gundt A, Trede I, Rensch K, Hunstein W: Long-term effects of 2′-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia. Leukemia 4:584, 1990
19. Thaler J, Grünewald K, Gattringer C, Ho AD, Weyrer K, Dietze O, Stauder R, Fluckinger T, Lang A, Huber H: Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: Lymphocyte subpopulations and residual bone marrow infiltration. Br J Haematol 84:75, 1993
20. Bouma GJ, Meer van der-Prins PMW, Bree van FPMJ, Rood van JJ, Claas FHJ: Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as non-radioactive alternative to labeling with chromium-51. Hum Immunol 35:85, 1992
21. Bouma GJ, Schanz U, Oudshoorn M, Meer van der-Prins PMW, Roelen DL, Rood van JJ, Claas FHJ: A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. Bone Marrow Transplant 17:19, 1996
22. Raemaekers J, Michiels J, Veer van 't MB, Kluin-Nelemans JC, Peetermans WEC, Schouten HC, Wijermans PW: Long-term maintenance treatment with fortnightly very-low-dose interferon-alpha in hairy cell leukemia: Results of the HOVON-14 study. Br J Haematol 87:233, 1994 (abstr, suppl 1)
23. Kaashoek JGJ, Mout R, Falkenburg JHF, Willemze R, Fibbe WE, Landegent JE: Cytokine production by the bladder carcinoma cell line 5637: Rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res 10:231, 1991
24. Cluitmans FHM, Esendam BHJ, Landegent JE, Willemze R, Falkenburg JHF: Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymphokine Cytokine Res 12:457, 1993
25. + subsets of T lymphocytes in monozygotic twins. J Immunol 150:2033, 1993
26. Struyk L, Kurnick JT, Hawes GE, Laar van JM, Schipper R, Oksenberg JR, Steinman L, Vries de RRP, Breedveld FC, Elsen van den PJ: T cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum Immunol 37:237, 1993
27. Posnett DN, Romagne F, Necker A, Kotzin BL, Sekaly R-P: First human TcR monoclonal antibody workshop. Immunologist 4:5, 1996
28. van Dongen JJM, van den Beemd MWM, Schellekens M, Wolvers-Tettero ILM, Langerak AW, Groeneveld K: Analysis of malignant T cells with the Vβ antibody panel. Immunologist 4:37, 1996
29. Terstappen LWMM, Shah VO, Conrad MP, Recktenwald D, Loken MR: Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 9:477, 1988
30. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD: Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61:1132, 1983
31. Jansen JH, Van der Harst D, Wientjens GJHM, Kooy-Winkelaar YMC, Brand A, Willemze R, Kluin-Nelemans JC: Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood 80:478, 1992
32. +) in hairy cell leukemia. Leukemia 7:46, 1993
33. Wen T, Mellstedt H, Jondal M: Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma. J Exp Med 171:659, 1990
34. Farace F, Orlanducci F, Dietrich P-Y, Gaudin C, Angevin E, Courtier M-H, Bayle C, Hercend T, Triebel F: T cell repertoire in patients with B chronic lymphocytic leukemia: Evidence for multiple in vivo T cell clonal expansions. J Immunol 153:4281, 1994
35. + T cells in patients with multiple myeloma and paraproteinemia. Blood 87:3297, 1996
36. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K: Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88:1887, 1996
37. Kook H, Goldman F, Padley D, Gilier R, Rumelhart S, Holida M, Lee N, Peters C, Comito M, Huling D, Trigg M: Reconstruction of the immune system after unrelated or partially matched T cell depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery. Blood 88:1089, 1996
38. + T cells in acute infectious mononucleosis. Nature Med 2:906, 1996